Gene · 3122
Papers4,458
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 4,458
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Extracellular vesicles released from melanoma cells constitutively expressing MHC class II promote immune evasion and cancer progression. | FEBS J | 2026 | 41603088 | PubTator, text mining | PubMed |
| PRC1 promotes immunosuppressive macrophages in sepsis via β-catenin/STAT3 signaling. | Cell Mol Life Sci | 2026 | 41588126 | PubTator, text mining | PubMed |
| Single-cell transcriptome sequencing revealing the microenvironment of breast fibroepithelial tumor. | Biochem Biophys Rep | 2026 | 41584304 | PubTator, text mining | PubMed |
| Immunotherapy Response Predictive Score Based on Tumor Microenvironment Profiles for Predicting Immunotherapy Outcomes in Advanced Head and Neck Cancer. | Technol Cancer Res Treat | 2026 | 41574715 | PubTator, text mining | PubMed |
| Free-floating long-term vascularized mesenchymal organoids. | iScience | 2026 | 41568151 | PubTator, text mining | PubMed |
| Exploring phenotype-related single-cells through attention-enhanced representation learning. | Genome Med | 2026 | 41566378 | PubTator, text mining | PubMed |
| Latent tuberculosis infection in high TB disease burden countries dysregulates cellular and immunological profiles which is further enhanced with uncontrolled hyperglycemia. | Sci Rep | 2026 | 41565868 | PubTator, text mining | PubMed |
| Transcriptomic profiling and machine learning uncover gene signatures of psoriasis endotypes and disease severity. | Commun Med (Lond) | 2026 | 41565778 | PubTator, text mining | PubMed |
| Causality between immune cells and HER2-breast cancer: A 2‑sample Mendelian randomization study. | Medicine (Baltimore) | 2026 | 41560039 | PubTator, text mining | PubMed |
| Aging reshapes the osteosarcoma ecosystem through immune dysfunction and tumor cell reprogramming. | Cell Oncol (Dordr) | 2026 | 41553639 | PubTator, text mining | PubMed |
| KRASG12/13 mutation modulates CRC outcomes via disrupting positive feedback between macrophage and CD4+ T cell. | iScience | 2026 | 41550738 | PubTator, text mining | PubMed |
| DNA methylation signature of cognitive reserve moderates CSF tau pathology in prodromal Alzheimer's disease. | Res Sq | 2026 | 41542061 | PubTator, text mining | PubMed |
| An Immune-privileged niche mediates immunotherapy resistance in esophageal carcinoma. | J Immunother Cancer | 2026 | 41539687 | PubTator, text mining | PubMed |
| Single-cell and multi-omic characterization of ex vivo expanded ASTRLs from stable kidney transplant recipients reveals a regulatory T cell phenotype. | Sci Rep | 2026 | 41535376 | PubTator, text mining | PubMed |
| Retinal Amyloid Clearance Enhanced by 40-Hz Light Flicker via MHC-II+ Microglia Regulation in Mice. | Invest Ophthalmol Vis Sci | 2026 | 41532701 | PubTator, text mining | PubMed |
| Inflammatory imbalance in ambulance patients is associated with sepsis and septic shock. | Cytokine | 2026 | 41520524 | PubTator, text mining | PubMed |
| Comic: explainable drug repurposing via contrastive masking for interpretable connections. | BMC Bioinformatics | 2026 | 41514421 | PubTator, text mining | PubMed |
| Interpreting the molecular and cellular landscape of PCOS through bulk transcriptomics, single-cell transcriptomics and machine learning. | J Ovarian Res | 2026 | 41501917 | PubTator, text mining | PubMed |
| A Single-cell Transcriptome-wide Association Study Reveals Susceptibility Genes for Age-related Hearing Loss. | Genomics Proteomics Bioinformatics | 2026 | 41495531 | PubTator, text mining | PubMed |
| Biomarker driven drug repurposing for Fuchs' endothelial corneal dystrophy (FECD): a computational study. | In Silico Pharmacol | 2026 | 41384081 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3122/papers?page=6